Profile data is unavailable for this security.
About the company
Centene Corporation is a healthcare company. The Company provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
- Revenue in USD (TTM)194.78bn
- Net income in USD-6.68bn
- Incorporated2001
- Employees61.10k
- LocationCentene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
- Phone+1 (314) 725-4477
- Fax+1 (302) 655-5049
- Websitehttps://www.centene.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Encompass Health Corp | -100.00bn | -100.00bn | 11.08bn | 23.56k | -- | 4.55 | -- | -- | -- | -- | -- | 24.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.4319 | -- | -- | -- | -- | -- | 12.52 | -- |
| Ensign Group Inc | 5.06bn | 343.97m | 12.40bn | 46.00k | 36.51 | 5.55 | 27.64 | 2.45 | 5.84 | 5.84 | 85.94 | 38.42 | 0.9984 | -- | 8.38 | 109,953.10 | 6.80 | 6.66 | 8.11 | 8.05 | 21.07 | 21.89 | 6.81 | 6.82 | -- | -- | 0.0597 | 5.16 | 18.72 | 16.05 | 15.44 | 15.07 | 20.77 | 4.77 |
| Universal Health Services Inc | 16.99bn | 1.38bn | 14.67bn | 86.00k | 11.16 | 2.05 | 7.33 | 0.8634 | 21.04 | 21.04 | 259.66 | 114.75 | 1.14 | -- | 7.08 | 197,587.30 | 9.43 | 6.68 | 11.52 | 7.94 | -- | -- | 8.24 | 6.62 | 0.9595 | 12.35 | 0.3913 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Centene Corp | 194.78bn | -6.68bn | 19.96bn | 61.10k | -- | 1.00 | -- | 0.1025 | -13.63 | -13.62 | 394.60 | 40.57 | 2.45 | -- | 10.30 | 3,187,840.00 | -8.39 | 0.4683 | -15.18 | 0.771 | 7.12 | 10.08 | -3.43 | 0.2365 | -- | -0.4145 | 0.4646 | -- | 19.44 | 11.88 | -302.06 | -- | -2.47 | -- |
| Tenet Healthcare Corp | 21.31bn | 1.41bn | 20.31bn | 74.48k | 14.92 | 4.81 | 6.29 | 0.9531 | 15.49 | 15.49 | 234.60 | 48.02 | 0.7271 | 10.89 | 8.06 | -- | 8.08 | 7.28 | 11.63 | 10.40 | 82.26 | 82.59 | 11.11 | 10.10 | 1.68 | 6.61 | 0.5948 | -- | 3.12 | 3.85 | -56.03 | 28.67 | 13.34 | -- |
| Humana Inc | 129.66bn | 1.19bn | 22.20bn | 65.68k | 18.77 | 1.26 | 10.43 | 0.1712 | 9.81 | 9.81 | 1,074.55 | 146.42 | 2.72 | -- | -- | -- | 2.74 | 4.86 | -- | -- | -- | -- | 1.01 | 2.05 | -- | 4.79 | 0.4109 | 19.21 | 10.11 | 10.94 | -1.57 | -18.81 | -10.75 | 3.02 |
| Quest Diagnostics Inc | 11.04bn | 988.00m | 22.76bn | 57.00k | 23.61 | 3.17 | 14.46 | 2.06 | 8.76 | 8.76 | 97.87 | 65.18 | 0.6816 | 39.03 | 8.14 | 193,596.50 | 6.20 | 8.03 | 7.25 | 9.31 | 33.32 | 34.94 | 9.10 | 11.33 | 0.9609 | 6.53 | 0.4377 | 29.29 | 11.78 | 3.18 | 14.09 | -7.06 | 4.74 | 7.68 |
| Labcorp Holdings Inc | 13.77bn | 855.20m | 23.43bn | 70.00k | 27.75 | 2.70 | 15.26 | 1.70 | 10.18 | 10.18 | 163.87 | 104.78 | 0.7466 | 19.61 | 6.13 | 196,647.10 | 4.64 | 6.16 | 5.56 | 7.33 | 28.45 | 32.18 | 6.22 | 9.17 | 1.35 | 5.51 | 0.3934 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Natera Inc | 2.12bn | -309.19m | 28.70bn | 4.42k | -- | 22.65 | -- | 13.56 | -2.28 | -2.28 | 15.69 | 9.10 | 1.24 | 13.57 | 7.14 | 478,452.50 | -18.12 | -30.60 | -23.17 | -38.82 | 63.66 | 51.43 | -14.61 | -40.61 | 3.13 | -- | 0.0603 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 52.24m | 10.63% |
| AQR Capital Management LLCas of 31 Dec 2025 | 31.80m | 6.47% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 26.23m | 5.34% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 21.42m | 4.36% |
| Geode Capital Management LLCas of 31 Dec 2025 | 13.27m | 2.70% |
| D. E. Shaw & Co. LPas of 30 Sep 2025 | 10.63m | 2.16% |
| Invesco Capital Management LLCas of 30 Sep 2025 | 10.34m | 2.10% |
| Harris Associates LPas of 30 Sep 2025 | 9.13m | 1.86% |
| Arrowstreet Capital LPas of 31 Dec 2025 | 8.59m | 1.75% |
| Norges Bank Investment Managementas of 31 Dec 2025 | 8.07m | 1.64% |
